SIREN : 481118305
HEMATITE is a French company founded 21 years ago, specialized in the sector Location de terrains et d'autres biens immobiliers. Based in LE MANS (72100), this company of category GE shows in 2024 a revenue of 4.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4 186 042 € | 4 092 479 € | 2 621 455 € | 3 937 472 € | 3 729 290 € | 3 463 149 € | 3 020 804 € | 2 684 851 € |
| Net income | 940 474 € | 855 612 € | 883 675 € | 208 941 € | 1 291 880 € | 1 102 291 € | 532 618 € | 239 512 € |
| EBITDA | 3 859 211 € | 3 473 400 € | 2 215 141 € | 3 127 994 € | 2 976 378 € | 2 704 425 € | 2 412 396 € | 2 081 424 € |
| Net margin | 22.5% | 20.9% | 33.7% | 5.3% | 34.6% | 31.8% | 17.6% | 8.9% |
In 2024, HEMATITE achieves revenue of 4.2 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +5.7%. Vs 2023: +2%. After deducting consumption (0 €), gross margin stands at 4.2 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 3.9 M€, representing 92.2% of revenue. Positive scissor effect: EBITDA margin improves by +7.3 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 940 k€, i.e. 22.5% of revenue. This profit can be retained or distributed to shareholders.
4 186 042 €
4 186 042 €
3 859 211 €
2 057 808 €
940 474 €
92.2%
The debt ratio (= Financial debt / Equity x 100) stands at 112%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 11.0 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 65.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
111.85%
46.095%
65.596%
10.958
71.4%
In 2024, the debt ratio of HEMATITE (111.85) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of HEMATITE (46.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of HEMATITE (10.96) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 279.35. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 29.2x. Operating income very largely covers interest expenses: high safety margin.
279.347
29.231
In 2024, the liquidity ratio of HEMATITE (279.35) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of HEMATITE (29.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 57 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 954 days. Excellent situation: suppliers finance 897 days of the operating cycle (retail model). WCR is negative (-7 days): operations structurally generate cash. Over 2016-2024, WCR increased by +95%, requiring additional financing.
-84 349 €
57 j
954 j
0 j
-7 j
Based on 169 transactions of similar company sales in 2024, the value of HEMATITE is estimated at 13 100 171 € (range 3 632 743€ - 23 500 855€). With an EBITDA of 3 859 211€, the sector multiple of 5.6x is applied. The price/revenue ratio is 0.81x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 169 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare HEMATITE with other companies in the same sector:
Voir toutes les statistiques du secteur Location de terrains et d'autres biens immobiliers
The revenue of HEMATITE in 2024 is 4.2 M€.
Yes, HEMATITE generated a net profit of 940 k€ in 2024.
The headquarters of HEMATITE is located in LE MANS (72100), in the department Sarthe.
The tax return of HEMATITE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
HEMATITE operates in the sector Location de terrains et d'autres biens immobiliers (NAF code 68.20B). See the 'Sector positioning' section above to compare the company with its competitors.